Treat myasthenia gravis with individualized doses of acetylcholinesterase inhibitors and immunomodulators

Author：  

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.27, Iss.7, 2011-07, pp. : 18-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Structure-Activity Relationship of Quaternary Acetylcholinesterase Inhibitors - Outlook for Early Myasthenia Gravis Treatment

By  

Current Medicinal Chemistry, Vol. 17, Iss. 17, 2010-06 ,pp. : 1810-1824

Bentham Science Publishers

Access to resources Recommend Favorite

Immunomodulatory treatment for myasthenia gravis

By  

Inpharma, Vol. 1, Iss. 1283, 2001-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Myasthenia Gravis: Therapy Is Complex

By  

Pharmaceutical Innovation, Vol. 11, Iss. 2, 2002-03 ,pp. : 30-31

Adis International

Access to resources Recommend Favorite

Mouse Models of Myasthenia Gravis

By  

Current Pharmaceutical Design, Vol. 21, Iss. 18, 2015-06 ,pp. : 2468-2486

Bentham Science Publishers

Access to resources Recommend Favorite

Diagnosis and Management of Autoimmune Myasthenia Gravis

By Angelini Corrado  

Clinical Drug Investigation, Vol. 31, Iss. 1, 2011-01 ,pp. : 1-14

Adis International

Access to resources Recommend Favorite